ScholarIQanswers from OpenAlex

Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy

PaperCitations, authors & open-access status

Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy have?

ScholarIQcitation count

Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy has 49 citations in the OpenAlex counts ScholarIQ stores.

When was Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy published?

ScholarIQyear

Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy has 2021 year in the ScholarIQ index.

What is the open-access status of Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy?

ScholarIQoa status

Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy has bronze oa status in the ScholarIQ index.

What is the DOI of Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy?

ScholarIQdoi

The DOI for Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy is on the source record.

What is the PMID of Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy?

ScholarIQpmid

The PMID for Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy is on the source record.

What is the OpenAlex record for Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy?

ScholarIQopenalex

The OpenAlex for Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial